Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders
CompletedNot applicableNCT03606668
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Participants with neurological disorders will be recruited to complete sessions of virtual reality (VR) immersion. VR has been shown to have therapeutic benefit in certain patient populations and requires further clinical study to determine the extent to which VR can be used to rehabilitate and reduce symptom burden. This study seeks to pilot newly developed VR methods and collect preliminary data in order to support research grants and inform larger clinical trials. Additionally, this proposed study will explore the tolerability and preliminary efficacy of Virtual Reality (VR), specifically to determine whether VR can acutely reduce the severity of symptom burden caused by neurological disorders.
Study details
- Official title
- Virtual Reality (VR) to Improve Quality of Life in Patients Diagnosed With Neurological Disorders
- Conditions
- Multiple Sclerosis
- Chronic Pain
- Neurological Disorder
- Interventions
- Device: HTC Vive Virtual Reality (VR) system
- Sponsor
- NYU Langone Health
- Start date
- 2018-06-20
- Primary completion
- 2020-03-02
- Sex
- All
- Age range
- from 18 Years to 79 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 18-79 years of age * Has been diagnosed by a clinician as having MS * Able to commit to the designated period of testing * Able to understand the informed consent process and provide consent to participate in the study * Capacity to complete study procedures as determined by screening personnel * A Brief Pain Inventory interference score of at least 3 or more. * SDMT Z-Score \> -3.0 * WRAT4 Standard Score \> or = 85 Exclusion Criteria: * Visual, auditory, and motor deficits that would prevent full ability to understand study * Visual, auditory, and motor deficits that would prevent full ability to operate VR equipment * Uncontrolled epilepsy * Current diagnosis of vertigo * Uncontrolled mood disorders * History of Psychosis or Schizophrenia * Expanded Disability Status Scale (EDSS) Score greater than 6.5 * Unable to tolerate or manipulate VR treatment procedures (as evidenced by VR capability assessment)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03606668